Greenberg (cited earlier) reports that he typically treats EDS patients with a combination of PRP and prolotherapy to maximize pain relief and tissue repair
Support for gut health : BPC-157 is known for its protective effects on the gastrointestinal tract, promoting overall digestive wellness
Conclusion The BPC-157 FDA approval status 2026 is unambiguous at the approval level: BPC-157 is not FDA approved, has no active IND, and has no registered human clinical trials
[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Park I.H., Um J.Y., Cho J.S., Lee S.H., Lee S.H., Lee H.M
Stay Connected with Portrait Care Subscribe to our email list and receive the latest insights, updates, and exclusive content delivered straight to your inbox.